The aim of this study was to specify in patients with tight mitral stenosis whether lung diffusing capacity could play a role in their exercise intolerance. A similar study was recently carried out in patients with moderate chronic heart failure.
Ten patients with tight mitral stenosis were studied before and 6 months after successful percutaneous transvenous balloon valvuloplasty and compared to six control subjects. Measurements of diffusing capacity, evaluated by the lung transfer factor (TLCO) and by the transfer coefficient (TLCO/VA), obtained at rest and during early recovery after cardiopulmonary exercise testing were performed. Cardiac output was determined non-invasively, both at rest and during exercise, using the carbon dioxide exponential rebreathing technique.
Prior to valvuloplasty, TLCO and TLCO/VA were not different at rest between the two groups. During exercise, patients differed from control subjects, with lower oxygen uptake (/ > <0001) and lower cardiac output at peak exercise (P<0001). These values at peak exercise were significantly correlated (/ > =002; r=0-75). Moreover, patients differed from control subjects at early recovery after peak exercise with an absence of increase in TLCO (P<0-05).
Six months after valvuloplasty, a decrease of both TLCO (/ ) <001) and TLCO/VA (P<005) was observed at rest. During exercise, comparison of patients demonstrated a significant increase of both peak exercise oxygen uptake (SLVO 2 , / > <001) and cardiac output (P<0001). At early recovery after peak exercise there was a significant increase in TLCO (P<005) and TLCO/VA (/><001), such that a ATLCO and a 4TLCO/VA appeared (P<005) identical to that observed in control subjects. Moreover, JSLVO 2 was significantly correlated in patients with AQ+ATLCOIWA. (P=002; r=0-72).
In conclusion, this study suggests a role, at least partial, of lung diffusing capacity in exercise intolerance in patients with tight mitral stenosis and in the improvement of their aerobic exercise capacity demonstrated after successful percutaneous balloon valvuloplasty. (Eur Heart J 1996; 17: 594-605)
Introduction
In a previous study, during early recovery after peak exercise we demonstrated an absence of increase in pulmonary diffusing capacity in patients with moderate chronic heart failure, in comparison to control subjects 1 ' 1 . This result suggests that pulmonary diffusing capacity may have a role, at least in part, in limiting aerobic exercise capacity in patients with limitation in effort due to cardiac disease If this hypothesis is correct, the cure for the underlying cardiac disease should restore the 'physiological' increase of pulmonary diffusing capacity in early recovery after peak exercise and should improve aerobic exercise capacity.
Mitral valve stenosis provides an ideal pathophysiological model to verify this hypothesis, since percutaneous valvuloplasty in patients with tight mitral stenosis' 3 ' can provide curative treatment with immediate and long-term positive results' 41 . However, before treatment, in patients with tight mitral valve stenosis, studies of exercise pulmonary diffusing capacity demonstrated either no change' 5 ' 6 ' or an increase' 7 ' -conflicting results. To our knowledge, exercise pulmonary diffusing capacity has never been studied before in patients following treatment.
Thus, the aim of this study was to specify whether lung diffusing capacity could play a role in exercise intolerance in patients with tight mitral stenosis. We therefore compared the measurements of diffusing capacity, evaluated by the lung transfer factor (TLCO) and by the transfer coefficient (TLCO/VA), obtained at rest and during early recovery after exercise. Measurements were taken using muscular exercise testing, in a group of normal subjects and in a group of patients with tight mitral stenosis, prior to and 6 months after successful percutaneous mitral valvuloplasty.
Methods

Subjects
Twenty subjects were studied (13 women and seven men), none significantly overweight. Ten consecutive subjects with tight mitral stenosis were selected for percutaneous transvenous balloon mitral valvuloplasty and 10 normal subjects volunteered to serve as controls.
The ten patients with severe symptomatic mitral stenosis comprised seven women and three men, aged 28 to 56 years (mean 44-5 ± 2-9], with class III heart failure (New York Heart Association classification). Eight patients demonstrated normal sinus rhythm and two had atrial fibrillation. All 10 patients were in a clinically stable condition at the time of the test, with no history of worsening heart failure or a change in cardiac medication in the previous 2 months. Tight mitral stenosis was assessed from clinical and radiological examinations and two-dimensional echocardiographic and Doppler studies. The mitral valve area was less than 1 cm 2 (mean 0-94 ± 0-04), calculated using the pressure half-time formula, and the mitral valve mean gradient was above 5 mmHg (mean 9-2 ± 1-2). Left ventricular systolic function was assessed by evaluating the echocardiographic shortening fraction, which was normal (mean 34-5 ± 022%). The possibility of performing a balloon valvuloplasty was determined according to transoesophageal echocardiographic valvular morphology criteria graded by using the worldwide Massachusetts General Hospital scoring system' 8 ', with a baseline mean score of 7-4 ± 0-5, and in the absence of left atrial or auricular thrombus as demonstrated by transoesophageal echocardiography. Severe mitral stenosis was confirmed by haemodynamic measurements obtained during the procedure just before the valvuloplasty.
None of the patients had a history of pulmonary disease, excluding consequences due to severe mitral stenosis, smoking (during the previous 5 years), implanted pacemaker, amiodarone or beta-blocker treatment, or exercise intolerance for any reason other than fatigue or dyspnoea.
The control group consisted of 10 sedentary subjects in normal physical and medical condition according to clinical, radiological, electrocardiographic, echocardiographic and spirographic examinations. None of them was a smoker, on medication or engaged in regular sports. From this control group, six subjects (four women and two men), aged 42 to 66 years (mean 50-6 ± 4-3) were selected in order to be comparable in age, height and body mass with the 10 patients with severe mitral stenosis before their balloon valvuloplasty (anthropometric characteristics are reported in Table 1 ). Informed consent to participate in this study was obtained from all patients and control subjects.
Mitral valvuloplasty
Valvuloplasty was performed successfully with the anterograde transseptal technique using an Inoue balloon. Procedures were considered successful if the final mitral valve area was greater than 1-5 cm 2 , or had increased more than 50% from baseline, without a prominent increase in mitral regurgitation' 3 '. Right and left heart pressures and mitral gradient were measured before and after valvuloplasty. Mitral valve area was calculated by the Gorlin formula'
91
. Immediately after valvuloplasty, the balloon valvotomy catheters were removed in order to take haemodynamic measurements. Afterwards, cine left ventriculography in the right anterior oblique projection was carried out to evaluate the severity of mitral regurgitation. Doppler mitral valve gradients were determined using standard echocardiographic techniques before, during and 6 months after valvuloplasty in all patients. Mitral valve area was calculated 6 months after valvuloplasty by Doppler echocardiography with Eur Heart J, Vol. 17, April 1996 Downloaded from https://academic.oup.com/eurheartj/article-abstract/17/4/595/539762 by guest on 31 December 2018 Exercise tolerance in patients with mitral stenosis 597 . Subjects wore noseclips and were studied in the sitting position. After the subject had adapted to the mouthpiece, the tidal volume was recorded at least four to six times to determine a regular end-expiratory baseline; the subject exhaled to residual volume and then rapidly inspired the gas mixture to total lung capacity (TLC). The inhaled gas mixture was: He=10%, O 2 =21%, carbon monoxide = 2800 ppm, and balance N 2 . Breath-holding at TLC was maintained by asking the subject to relax against the closed valve. After 10 s of breath-holding, the subject rapidly exhaled to residual volume. The first 750 ml were set as the wash-out volume; the next 600 ml were used as the sample volume. The breath-holding time was computed according to the Jones-Meade timing technique 1 ' 31 . Repeat tests were separated by a washout period of at least 4 min. Manoeuvres with breath-holding time above 11 s or less than 9 s were rejected. Unless the inspiratory volume was greater than 90% of the subject's vital capacity, and unless there were at least two technically acceptable tests with TLCO that differed by less than 5%, the test was repeated or rejected. Results are expressed as the mean values of the two closest measurements. The single-breath alveolar volume (VA) was derived by helium dilution and expressed in litres (BTPS conditions); the TLCO/VA ratio was expressed in ml carbon monoxide (STPD )/min/mrnHG/l( BT p S ) and thereafter expressed as percent of predicted values. The VA was corrected for the concentrating effect of absorbing CO 2 before measuring the exhaled gas concentrations. The TLCO/VA (BTPS), and all measurements were standardized to a haemoglobin concentration of 14-7
Cardiac output measurement (Q)
Cardiac output (Q) was determined non-invasively, both at rest and during exercise, using the carbon dioxide exponential rebreathing technique 1171 through a previously reported method'
11181
. Expired CO 2 was continuously sampled at the mouth for analysis of CO 2 , using a rapid response infrared analyser (Rubis 3000, Cosma, France). The end-tidal carbon dioxide tension (PETCO 2 , mmHg) was calculated from the average of Eur Heart J, Vol. 17, April 1996 the last 10 breath cycles prior to the rebreathing manoeuvre. Immediately following this procedure, subjects performed a 10-12 s CO 2 rebreathing manoeuvre, as described by Jones et a/. [20) , and cardiac output (Q) was then calculated according to the Fick formula: [Q (1. min_ ,) = VCO 2 (cl. min " ')/C(v-a) CO 2 (ml.dl"')] where C(v-a) CO 2 is the venous-arterial content difference for CO 2 .
Exercise testing
The exercise test was conducted on a cycle ergometer (Monark 864) and ventilatory gas exchanges were measured with a breath-by-breath automated exercise metabolic system (CPX, Medical Graphics, Saint Paul, Minnesota, U.S.A.). Subjects breathed through a low resistance valve. Expiratory airflow was measured with a pneumotachograph connected to a pressure transducer. Expired gases were analysed for O 2 with a zirconia solid electrolyte O 2 analyser and for CO 2 with an infrared analyser. Before each test, the volume was calibrated by five inspiratory strokes with a 3-1 pump and the gas analysers with two gas mixtures of known O 2 and CO 2 concentrations. The incremental exercise test consisted of 3 min unloaded pedalling at 50 rpm and of 30 W increments every 3 min thereafter, until the subject's maximal exercise tolerance was reached. The minute ventilation (VE L/min BTPS ), oxygen uptake (VO 2 LV min STPD ), carbon dioxide production (VCOJ, ventilatory equivalent for O 2 (VE/VOj) and CO 2 (VE/VCOz), respiratory ratio (R) and the oxygen pulse (O 2 pulse) were determined each minute during the last 20 s of each stage on an integral number of respiratory cycles.
The ventilatory reserve (VR) was calculated from the maximal values of measured (VE max) and estimated ventilation (VE max estimated = FEV, x 35) as follows: VR (%)=100-(100x VE max/VE max estimated). Oxygen saturation (O 2 Sat) was measured non invasively during both exercise and recovery using a finger oxymeter (Spacelabs 90501). A 3-lead electrocardiogram (D 2 , V 2 , V 5 ) was continuously monitored with a cardioscope (Q 3000, Quinton instrument company, Seattle, U.S.A.).
We used the predicted values of Jones' 201 for VO 2 max and those of Lange-Anderson' 2 ' 1 for the HR max (predicted HR max in beats/min = 210-0-65 x age in years). HR reserve (predicted HR max-HR max) and HR response [HRR = (HR max-HR rest/VO 2 max -VO 2 rest)], where HR max was the heart rate at maximal exercise and HR rest was the heart rate at rest, were calculated' 221 .
Protocol
The evaluation included clinical, radiological and transthoracic echocardiographic examinations, spirometric values at rest and exercise testing with cardiac output determination and diffusing capacity measurements. Controls were evaluated once and patients with tight mitral valve stenosis were studied before and 6 months after successful valvuloplasty.
The subjects were first submitted to resting spirometry, as well as to a TLCO and blood gas analysis. TLCO measurement was carried out at least twice at rest at 4 min intervals, after explaining the test procedure to the subjects. Before exercise testing, subjects received standardized instructions about the procedure. Resting ventilatory variables were measured for a 2 min period in order to acquaint the subject with the respiratory procedure. Each subject then performed an incremental symptom-limited exercise test in a seated position. Cardiac output was determined at rest, at each stage of effort and during recovery. Immediately after peak exercise, and thus during early recovery, within the first 5 min after the completion of the exercise, the subjects underwent a second TLCO measurement.
All the tests were performed between 0900 h and HOOh.
Statistics
The data are expressed as mean ± standard error of the mean (m ± SEM). Both groups were studied at maximal exercise and at the same work load. Group differences were evaluated using a two way analysis of variance (group x work load) and using a Student's t-test for independent samples to compare controls and patients before mitral valvuloplasty and for dependent samples to compare patients before and after valvuloplasty. Multiple regression analysis of percentage of change in VO 2 between rest and maximal effort was performed with changes in cardiac output (dQ) and in zJTLCO or zfTLCO/VA added to AQ. A P value <005 was considered statistically significant.
Results
Before valvuloplasty
A clear exercise limitation was found in the mitral stenosis group with a VO 2 of 14-60 ± 1-75 instead of 27-48 ± 1 -92 ml. min ~' . kg " ' obtained in the control group (/ > <0-001). This limitation was, at least in part, due to the low maximal of cardiac output, in comparison with the control group (/>< 0-001; see Table 3 ). There Q=cardiac output (1. min '); ns = not significant; VO 2 = oxygen uptake (ml. min ' . kg '); TLCO=diffusing capacity and TLCO/VA = transfer coefficient for carbon monoxide (%); *P<005; TLCO or TLCO/VA compared at rest and at early recovery was a significant correlation between variations in VO 2 and in cardiac output between rest and maximal effort (P=Q-02; r = 0-75). At rest, there was no significant difference in the diffusing capacity and transfer coefficient between the two groups. During exercise, on the other hand, no increase in diffusing capacity was observed in patients with tight mitral stenosis, such that there was no difference in TLCO between rest and early recovery after peak exercise (zfTLCO), as opposed to the control group (+9-50±3-34%; P<005). This observation could contribute, at least partially, to exercise limitation found in the mitral stenosis group. In both groups, the variations during exercise of the transfer coefficient were similar to those of the diffusing capacity but with no significant differences. Results are summarized in Table 3 .
Six months after valvuloplasty
Clinical, spirometric and blood gas results Clinically, symptomatic improvement was seen in all 10 patients, nine of them with NYHA grade II dyspnoea and one with grade I dyspnoea, whereas before valvuloplasty, all patients had grade III dyspnoea; the same was true haemodynamically with stable Doppler indices and no significant difference observed 6 months after valvuloplasty between these indices compared with measurements obtained immediately after valvuloplasty ( Table 2) .
Comparison of spirometric values at rest in patients with mitral stenosis before and 6 months after valvuloplasty demonstrated a trend towards an increase in their FEV, (measured, P=0\3 and measured/ predicted, P=0-ll), no change in their FVC and a significant increase in their Tiffeneau's ratio (FEV,/VC; P<005). These results indicated a decrease in airway resistances in these patients. Arterial blood gas levels were not significantly different (see Table 4 ).
Lung diffusing capacity at rest and during exercise
Six months after valvuloplasty, paradoxically, a significant decrease of both the TLCO (/ > <001) and the TLCO/VA (F<005) was observed at rest. During exercise, a significant increase in the TLCO (/ > <005) as well as in the TLCO/VA (/><001) was found, such that a zfTLCO and a ^TLCO/VA appeared (+9-60 ± 3-49% for TLCO and +12-90 ± 3-47% for TLCO/VA). Therefore, zfTLCO and zJTLCO/VA, before and 6 months after valvuloplasty, were significantly different in patients (/><005). Their ^TLCO obtained 6 months after valvuloplasty was identical to that observed in control subjects (+9-60 ±3-49% for patients 6 months after valvuloplasty vs +9-50 ± 3-34% for the control group) and their ATLCOFVA was higher, but not significantly, when compared with the control group (P=0-19 ; see Table 5 ). 
Aerobic exercise capacity
There was also a significant increase in the VE max Comparison of exercise parameters before and 6 months (/ > <001), combined with a significant decrease in ventiafter valvuloplasty showed a marked improvement in latory reserve, reflecting greater use of patient respiraexercise capacity, with a significant increase in the tory capacity at maximal effort. Maximal effort was maximal workload reached (P<0-05), and in the confirmed by the significant increase of R (7><005; see symptom-limited oxygen uptake (SLVO 2 max; P<0-01). Table 6A ).
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Concerning the cardiac parameters, the maximum heart rate reached increased significantly 6 months after the valvuloplasty (/ > <001), with a consequent significant decrease in the HR reserve (/ > <001). However, the HR response, the O 2 Sat max and most notably the O 2 pulse max were not significantly different (see Table 6B ). Study of cardiac output during exercise demonstrated a significant increase beginning at 30 W (/ > <001) and, most noticeably, at maximal exercise (/ > <0001; see Table 5 ). Between rest and maximal effort, variations in VO 2 and in cardiac output (zfQ) tended to be correlated (/>=006; r=0-61). That correlation became significant when zJTLCO/VA was added to ^Q (P=002; r=0-72).
Discussion
This study confirms our hypothesis that lung diffusion limitation has a partial role in exercise intolerance in patients with tight mitral stenosis.
First, we have shown that before treatment there was no increase in pulmonary diffusing capacity early recovery after peak exercise and there was a decrease in aerobic exercise capacity, in patients with tight mitral stenosis, in comparison to control subjects. These results are similar to those which we have previously reported in patients with moderate chronic heart failure 1 ' 1 . Second, 6 months after successful percutaneous mitral valvuloplasty, and thus after curative treatment, we confirm the reappearance in these patients of a 'physiological' increase in pulmonary diffusing capacity early recovery after peak exercise, and an improvement in their aerobic exercise capacity. Moreover, after valvuloplasty, the variation between rest and maximal effort in patients' oxygen uptake was significantly correlated with the variation in cardiac output added to the variation in transfer coefficient. ' . In this study, all the subjects had satisfactory lung volumes, normal haemoglobin concentrations, and a relatively short breath-holding time was used. In this study we were also interested in looking at the transfer coefficient of carbon monoxide (TLCO/VA), since this ratio is linked to the carbon monoxide transfer per unit of parenchyma ventilated' 161 . Single-breath determination of TLCO and TLCO/VA during exercise is more difficult to measure routinely than at rest. Patients should cycle for 3 min at each workload, continue to cycle and perform the breath-holding test, then pause for 5 min rest before the next level of exercise 1271 . This methodology was not suitable for this study because maximal exercise capacity and cardiac output during exercise by CO 2 rebreathing method measurements were being examined. Moreover, a breath-holding time of 10 s, which would be needed for single-breath determination of TLCO and TLCO/VA, is impossible to perform at peak exercise for both normal subjects and' patients. Similar heart rates would be more adapted for comparison of TLCO and TLCO/VA values between at rest and peak exercise. However, this is not feasible due to tachycardia observed at peak exercise.
Methodology
Manier et fl/.' 281 recently studied pulmonary diffusing capacity during early recovery from a progressive maximal exercise, with the use of the single-breath breath-holding method. By this approach, they reported an approximate 13% increase in pulmonary diffusing capacity at early recovery in well-trained subjects (within 2 min) after peak exercise, in comparison with resting values (/><001). We therefore used this methodology to evaluate pulmonary diffusing capacity variations during exercise in a previous study in patients with moderate chronic heart failure 1 ' 1 and similarly in this present study. In these two studies this approach was found to be sensitive enough to demonstrate an approximate 10% physiological increase in pulmonary diffusing capacity at early recovery (within 5 min) after peak exercise in the two control groups. It also confirmed the reappearance of this approximate 10% 'physiological' increase of early recovery pulmonary diffusing capacity in patients after successful valvuloplasty.
To determine cardiac output, we used the CO 2 rebreathing method with the same methodology we recently reported in patients with chronic heart failure, in comparison to control subjects 1 '
1
. Studies performed at rest and during exercise confirmed that the exponential CO 2 rebreathing method for measurements during exercise was more accurate and better tolerated than the equilibrium CO 2 . In this study, improvement was confirmed at 6 months for all patients, by both clinical and Doppler indices. Performing a percutaneous valvuloplasty avoided pleural and pulmonary drawbacks of surgical intervention, and therefore enabled unaltered comparisons of pulmonary function before and after curative treatment in these patients.
Spirometric and aerobic exercise capacity improvements
Changes in spirometric values observed 6 months after valvuloplasty showed a trend towards improvement in measured FEV, (/ > =013), which was confirmed by the measured/predicted FEV, (f=011) and especially a significant increase in Tiffeneau's ratio (/ > <005) since the FVC remained unchanged in this study (Table 4) . Yoshioka et al. noted an increase in both the FEV, and the FVC after valvuloplasty which explained the absence of change in the Tiffeneau's ratio in their study 1251 . Nevertheless, their comparative study was completed only one week after valvuloplasty and thus its results could not be directely compared with ours. The increase in FEV, and in TifFeneau's ratio that we observed after 6 months suggests a reduction in airway obstruction.
In subjects with severe mitral stenosis, before valvuloplasty, a marked limitation in aerobic exercise capacity was observed along with a clear reduction in oxygen uptake at maximal exercise as compared to the control group. Maximal exercise in patients was confirmed by a mean respiratory gas exchange ratio above 1.1 at peak exercise. Although this limitation was expected, it has not always been demonstrated: marked limitation in the recent Marzo et al. study 1371 with data comparable to ours, moderate limitation in Blackmon et al. [34] and in Cohen Solal et al. [38 \ and no change in limitation in one third of the cases in Hugenholtz et a/.' 391 . These discrepancies might be related to differences in illness severity of patients included in these studies. Furthermore, this limitation in exercise did not seem to be directly correlated with mitral valve area evaluated at rest'
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. And to our knowledge, oxygen uptake was not evaluated in these studies in comparison to a control group. A significant reduction in cardiac output was observed at maximum exercise before valvuloplasty. This reduction in cardiac output has already been reported in similar patients in haemodynamic studies during effort using cardiac catheterization' 341 or the echocardiographic method' 401 but, as far as we know, has not been reported using methods similar to ours.
Six months after valvuloplasty, the improvement in exercise capacity was clearly demonstrated in this study by the significant increase in max work load, especially concerning the measured SLVO 2 max (+53%; /*<001) as well as the measured/predicted SLVO 2 max (+49%; P<0-0\), the minute ventilation and the respiratory gas exchange ratio (Table 6A ). An improvement after valvuloplasty was also recently reported at 27-1 =t 11-6 months in max SLVO 2 [4] and at 3 months for all of these parameters' 371 . In addition, a significant decrease in ventilatory reserve was observed in our study, which suggests better recruitment of the alveoli, as confirmed by the significant increase in max R' 4 ' 1 .
As could have been predicted (although never reported during exercise using the CO 2 rebreathing method to our knowledge) cardiac output 6 months after valvuloplasty was significantly increased beginning at the 30 W (/ > <001) stage onwards, and especially at maximum effort ( + 64%; i><0001; Table 5 ). This naturally contributed to the clear improvement in exercise capacity in these patients, as assessed by the nearly significant (P=006) correlation between AVO 2 and zJQ during exercise 6 months after valvuloplasty.
The other cardiac parameters changed little 6 months after valvuloplasty, except for a significant increase in heart rate (HR) and a consequent significant decrease in the HR reserve (Table 6B) , which was not explained by therapeutic changes (breaks in digitalis or amiodarone treatments). In particular, as the max SLVO 2 and HR increased together, no modification in the max O 2 pulse was observed, unlike the significant increase reported in the Chen et al. study 141 .
Pulmonary diffusing capacity
Physiologically, as we detailed in a previous report'' 1 and as observed in our control group, the pulmonary diffusing capacity increases with effort' , using the same methodology as ours. Pulmonary diffusing capacity then returns to its resting value at 15 and 30 min after peak exercise 1281 . At 2-3 h post exercise, an approximate 15% reduction in pulmonary diffusing capacity takes place, whereas systolic cardiac function is normal and total lung capacity increases. This could reflect a physiological sub-clinical pulmonary interstitial oedema, as suggested by Rasmussen et al. [42 \ After 20 h following exercise, pulmonary diffusing capacity normalizes' 421 . In our study, prior to valvuloplasty, TLCO and TLCO/VA at rest were not significantly different (P values at 0-26 and 0-36 respectively) between patients with severe mitral stenosis and the control group (Table  3) . These results are in agreement with previous studies of similar subjects with mitral stenosis' 71 , but in conflict with others'
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. Indeed, significant decreases in TLCO and TLCO/VA at rest were reported but particularly in patients with a longer disease evolution' 43 -441 . Anatomical alterations of the membrane have been described in patients with mitral stenosis with intimal changes in small lung vessels, fibrosis or thickening of the alveolar walls and an increase in the thickness of the respiratory membrane and consequently in its resistance 1431 . According to these alterations, a decrease in diffusing capacity should be observed at rest. But the increase in pulmonary arterial pressure described at rest in patients with mitral stenosis' 91 leads to a confirmed higher recruitment of the pulmonary capillary blood volume 16 ' 43 -441 and therefore probably counterbalances, at rest, negative effects of the impaired membrane in diffusing capacity.
The early recovery after peak exercise diffusing capacity in these patients did not increase and was Eur Heart J, Vol. 17, April 1996 significantly lower than that of the control group (Table  3) . These results confirm those that we have previously reported during exercise in patients with moderate chronic heart failure 1 ' 1 , suggesting a similar time course in pulmonary diffusing capacity during exercise in patients with limitation in effort related to an underlying cardiac disease. Thus, the absence of increase in diffusing capacity during exercise in patients with mitral stenosis could be related, as suggested in patients with moderate chronic heart failure 1 ' 1 , to an increase in interstitial pulmonary oedema. This is a possible explanation since a worsening in anatomical lesions of the membrane was unlikely in such a short time course. Furthermore, a significant increase in pulmonary artery pressure, which might lead to an increase in pulmonary capillary blood volume and thus diffusing capacity, has been demonstrated during exercise in these patients' 9 ' 451 . Lastly, the shorter exercise time performed by patients in comparison to control subjects seems unlikely to explain the reduction in the exercised-induced improvement in diffusing capacity observed in patients with mitral stenosis, since change from rest to peak exercise in diffusing capacity observed in this study did not significantly correlate with the level of exercise or with the increase in cardiac output. Nevertheless, to definitively test this last hypothesis, we have to conduct a new study to compare diffusing capacity registered in patients and controls at the same level of exercise, since its measurement can only be obtained at early recovery after exercise.
Six months after valvuloplasty, pulmonary diffusing capacity at rest was significantly lowered in this study, whether evaluated using the TLCO (P<001) or the TLCO/VA (P<005; Table 5 ). This apparently paradoxical decrease had also been reported in a study completed within a week after valvuloplasty by Yoshioka et a/.' 251 in patients similar to ours, with diffusing capacity prior to mitral valvuloplasty not significantly different from that of the control group. However, Ray et al. 144^ recently reported 3 months after valvuloplasty no change in at-rest pulmonary diffusing capacity; but in their study TLCO was already reduced at baseline (mean, 25% of predicted), unlike in the Yoshioka study and in our own. In this study, the decrease in diffusion observed at rest, 6 months after valvuloplasty, is unlikely to be related to a worsening of anatomical abnormalities of the membrane after valvuloplasty or to a decrease in haemoglobin concentrations, which remain unchanged.
We therefore hypothesize that this decrease in diffusion observed at rest is linked to the decrease in mean pulmonary artery pressure, as Groen et al. [46] have recently reported in the first postoperative year in cardiac transplant recipients, with a mean decrease in DLCO significantly correlated with the change in their pulmonary arterial pressure (P<0001). Indeed, a marked decrease in mean pulmonary artery pressure is recorded at rest immediately and 6 months after valvuloplasty in our study ( , should result in an improvement in diffusing capacity during exercise after valvuloplasty, or at least in a return to its initial level prior to valvuloplasty. Indeed, a reappearance of a 'physiological' increase in early recovery after peak exercise pulmonary diffusing capacity is observed in patients, with a similar percentage increase to that observed in the control group (mean +9-60% in patients versus +9-50% in controls for TLCO). According to the small number of patients and controls included in our report, these preliminary results have to be confirmed in more extensive studies. Nethertheless, they support the explanation of the paradoxical reduction in diffusion observed at rest after valvuloplasty by the decrease in at-rest pulmonary artery pressure, since exercise testing appears to correct this reduction. Furthermore, the reappearance after curative treatment of a 'physiological' increase in early recovery after peak exercise pulmonary diffusing capacity seems to be in agreement with a possible role of the absence of increase in this capacity in patients' limitation in effort due to cardiac disease, as we suggested above, in addition to other well-known factors such as peripheral muscular abnormalities. Indeed, the weak correlation (P-0-06) between zJVO 2 and dQ during exercise 6 months after valvuloplasty was improved when JTLCO/VA was added to JQ and became significant (P=0-02). Although correlations between exercise parameters and exercise performance do not necessarily indicate cause, this higher correlation suggests a role, at least partial, of the improvement in pulmonary diffusion capacity in the improvement of maximal oxygen uptake in these patients.
Which determinants could be speculated to cause this increase in early recovery after peak exercise pulmonary diffusing capacity that occurred after valvuloplasty? This increase does not reflect the ability to generate the same peak pulmonary artery pressure (PAP), nor is it linked to a greater increase in PAP during exercise before and after valvuloplasty, since a smaller increase in PAP after valvuloplasty, as compared to before valvuloplasty, has been demonstrated at peak exercise and at the same submaximal ergometer workload (42 ± 12 mmHg at 3 months after, vs 61±17mmHg before, i><0-01, n = 24) t45 -
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. Moreover, this increase is probably not linked to an increase in pulmonary capillary blood volume during exercise, since this volume decreases and normalizes at rest after valvuloplasty 1441 , and increases during exercise in proportion to the elevation of pulmonary artery pressure, which is less important after valvuloplasty than before, as reported above. The reappearance after valvuloplasty of this increase in early recovery after peak exercise pulmonary diffusing capacity is also unlikely to be linked to an increase and normalization of the duration of blood-air contact, since before valvuloplasty there was no element suggesting insufficiency in the duration of this contact.
We therefore suggest that the reappearance of this 'physiological' increase could be related to an improvement in membrane permeability at early recovery after peak exercise. This improvement could be due to a time-dependant change in anatomical characteristics of the membrane, with a progressive reconstruction of the alveolocapillary membrane, as suggested by Jahnke et alS 49^ who observed at rest a higher diffusion capacity in long-term survivors after heart transplantation than in short-term survivors. But in patients with tight mitral stenosis, Ray et a/. [44) reported over a 3-month period after valvuloplasty a normalized pulmonary capillary volume without improvement in the at-rest diffusing capacity, implying enduring structural abnormalities of the alveolar capillary membrane. Long-term studies of diffusing capacity and capillary volume after valvuloplasty are therefore needed to clarify eventual changes in anatomical characteristics of the membrane. The improvement in membrane permeability at early recovery after peak exercise could also be due to functional change, such as a decrease in membrane interstitial oedema. This hypothesis could be related to a better interstitial liquid resorption by the lymphatic system. In severe chronic mitral stenosis at rest, there is no alveolar oedema as a result of increased elimination by the lymphatic system. However, interstitial oedema, has been confirmed in patients by high resolution computed tomography 1501 , due to limited increase in elimination capacity 151 '. During effort and before valvuloplasty, it may be impossible to increase lymphatic resorption to normal levels as it is already at the maximum, leading to an increase of membrane resistance. This increase, possibly related to overworked interstitial liquid resorption by the lymphatic system and which could be called 'humid membrane', was also suggested in our laboratory in 'extreme' athletes. This could explain severe and paradoxical hypoxia at maximum effort' 52 '. After valvuloplasty, left atrial and pulmonary artery pressures decreased' 36 ' 45 ' 481 which could explain the disappearance or at least a reduction in interstitial oedema making resorption by the lymphatic system easier because it is no longer overworked. During exercise, this would influence a possible improvement in membrane permeability after valvuloplasty.
Conclusion
This study confirms a dramatic improvement in aerobic exercise capacity in patients 6 months after valvuloplasty for severe mitral stenosis. In particular it confirms after valvuloplasty: (1) haemodynamic improvement by a significant increase in cardiac output during exercise as studied for the first time, to our knowledge, by CO 2 rebreathing method; (2) a decrease in alveolar-capillary diffusing capacity observed at rest, most likely linked to a decrease in pulmonary artery pressure and not to a worsening of membrane resistance, and; (3) it suggests the reappearance in these patients of a 'physiological' increase in early recovery after peak exercise pulmonary diffusing capacity.
These data, in agreement with those that we previously reported in patients with chronic heart failure 1 '', suggest that diffusing capacity, and therefore pulmonary function, may be involved, in addition to others factors such as peripheral muscular abnormalities, in exercise intolerance in patients with cardiac disease.
